Secondary Registration Statement. If the Company has not previously filed a Subsequent Registration Statement, the Company shall, on or before October 8, 2018 (the “Filing Deadline”), use its best efforts to prepare and file with the Commission a Registration Statement on Form S-1 or S-3, as appropriate (the “Secondary Registration Statement”; where used hereafter, “Registration Statement” shall mean either a Subsequent Registration Statement which includes the Registrable Securities, or the Secondary Registration Statement, as applicable), relating to the resale of the Shares by the Purchasers on a continuous basis pursuant to Rule 415 under the Securities Act.
Appears in 1 contract
Secondary Registration Statement. If the Company has not previously filed a Subsequent Registration Statement, the Company shall, on or before October 8, 2018 the date that is thirty (30) days after the Closing (the “Filing Deadline”), use its best commercially reasonable efforts to prepare and file with the Commission a Registration Statement on Form S-1 or S-3, as appropriate (the “Secondary Registration Statement”; where used hereafter, “Registration Statement” shall mean either a Subsequent Registration Statement which includes the Registrable Securities, or the Secondary Registration Statement, as applicable), relating to and providing for the resale of the Shares by the Purchasers on a continuous basis pursuant to Rule 415 under the Securities Act.
Appears in 1 contract
Secondary Registration Statement. If the Company has not previously filed a Subsequent Registration Statement, the Company shall, on or before October 8, 2018 the date that is forty-five (45) days after the Closing (the “Filing Deadline”), use its best efforts to prepare and file with the Commission a Registration Statement on Form S-1 or S-3, as appropriate (the “Secondary Registration Statement”; where used hereafter, “Registration Statement” shall mean either a Subsequent Registration Statement which includes the Registrable Securities, or the Secondary Registration Statement, as applicable), relating to the resale of the Shares by the Purchasers on a continuous basis pursuant to Rule 415 under the Securities Act.
Appears in 1 contract
Sources: Stock Purchase Agreement (Crinetics Pharmaceuticals, Inc.)